AI & Enterprise
Panasonic Korea launches Epredia cancer diagnosis pathology solutions in South Korea
Panasonic Korea said on Sept. 7 it will introduce Epredia anatomical pathology solutions for cancer diagnosis in South Korea. Epredia is a subsidiary of Japan-based healthcare company PHC Holdings Corporation and provides precision cancer diagnostic solutions. PHC Holdings Corporation spun off from Panasonic Healthcare and became independent in 2014. Epredia offers products covering pathology workflows, and Panasonic Korea plans to supply them to domestic pathology and research customers.
